ストックスクリーナーアプリを入手
103.72
0.53%
0.55
アフターアワーズ：
103.72
前日終値:
$103.17
開ける：
$103.4
24時間の取引高:
300.50K
Relative Volume:
0.50
時価総額：
$907.13M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.68%
1か月 パフォーマンス:
+3.31%
6か月 パフォーマンス:
+17.36%
1年 パフォーマンス:
+20.13%
1日の値動き範囲:
$102.44
$103.72
1週間の範囲:
$102.44
$104.30
52週間の値動き範囲:
$77.67
$104.47
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
PPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
103.72 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.31 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
683.17 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
686.19 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
261.54 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
613.12 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf (PPH) 最新ニュース
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Large Volume Increase Following Dividend Announcement - Defense World
Osaic Holdings Inc. Has $1.95 Million Stake in VanEck Pharmaceutical ETF $PPH - Defense World
VanEck ETF TrustVanEck Pharmaceutical ETF announces Quarterly dividend, payable on December 31, 2025 - marketscreener.com
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Benzinga
Pharma's $370B Bet on America: The ETF Plays for 2026 - The Globe and Mail
Why PPH Keeps Working When Single Themes Break (NASDAQ:PPH) - Seeking Alpha
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal - sharewise.com
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.6069 - MSN
Fisher Asset Management LLC Sells 1,263,699 Shares of VanEck Pharmaceutical ETF $PPH - Defense World
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight - Benzinga
Bank of Montreal Can Sells 4,190 Shares of VanEck Pharmaceutical ETF $PPH - Defense World
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
VanEck Pharmaceutical ETF (Nasdaq:PPH) Stock Quote - FinancialContent
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - TradingView
Avalon Trust Co Lowers Position in VanEck Pharmaceutical ETF $PPH - Defense World
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' - Benzinga
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? - TradingView
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.4110 - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
Top Pharmaceutical Companies Shaping The Future Of Healthcare - Seeking Alpha
Top Pharmaceutical Companies Shaping the Future of Healthcare - VanEck
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet - Benzinga
Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy? - Insider Monkey
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - sharewise.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - The Globe and Mail
Pharmaceutical ETF on track for best week since 2020 - MarketWatch
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Vaneck Pharmaceutical Etf (PPH) 財務データ
Vaneck Pharmaceutical Etf (PPH) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.95%
0.31%
大文字化:
|
ボリューム (24 時間):